Novo Nordisk CEO faces US Congress scrutiny over weight-loss drug pricing
U.S. Senator Bernie Sanders is set to question Novo Nordisk CEO Lars Jorgensen on Tuesday over the drugmaker's prices for its ...
MarketWatch16m
Novo Nordisk CEO set to defend Ozempic, Wegovy prices on Capitol Hill
The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish ...
Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders
Novo Nordisk's CEO said the complexities of the U.S. healtchare system prevented access to $1,349 Wegovy.
HealthLeaders Media26m
Novo Nordisk CEO faces Congress scrutiny over weight-loss drug pricing
Sen. Bernie Sanders (I-VT) is set to question Novo Nordisk CEO Lars Jorgensen on Tuesday over the drugmaker's prices for its popular weight-loss and diabetes medicines that can cost Americans more ...
kffhealthnews33m
US Severe Obesity Rate Swells To 40%
About 1 in 10 of survey respondents indicated they are severely obese. It's too soon to know whether obesity treatments and drugs will ease the problem, researchers say. Meanwhile, Novo Nordisk's CEO ...